BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8809956)

  • 1. Bacterial contamination of peripheral blood progenitor cells for transplantation.
    Jestice HK; Farrington M; Hunt C; Matthews I; Scott MA; Foreman J; Marcus RE
    Transfus Med; 1996 Jun; 6(2):103-10. PubMed ID: 8809956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation.
    Larrea L; de la Rubia J; Soler MA; Ribas P; Fernández JM; Picón I; García-Boyero R; García-Bellés C; Roig R
    Haematologica; 2004 Oct; 89(10):1232-7. PubMed ID: 15477209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts.
    Kamble R; Pant S; Selby GB; Kharfan-Dabaja MA; Sethi S; Kratochvil K; Kohrt N; Ozer H
    Transfusion; 2005 Jun; 45(6):874-8. PubMed ID: 15934984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does microbial contamination influence the success of the hematopoietic cell transplantation outcomes?
    Dal MS; Tekgündüz E; Çakar MK; Kaya AH; Namdaroğu S; Batgi H; Bekdemir F; Uncu Ulu B; Yiğenoğlu TN; Kılınç A; İskender D; Uğur B; Koçubaba Ş; İskender G; Altuntaş F
    Transfus Apher Sci; 2016 Aug; 55(1):125-8. PubMed ID: 27184293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial contamination of peripheral blood stem cell collections.
    Attarian H; Bensinger WI; Buckner CD; McDonald DL; Rowley SD
    Bone Marrow Transplant; 1996 May; 17(5):699-702. PubMed ID: 8733684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial contamination of hematopoietic progenitor cell products.
    Namdaroğlu S; Tekgündüz E; Bozdağ SC; Durgun G; Sarıca A; Demiriz IŞ; Koçubaba S; Iskender G; Kayıkçı O; Altuntaş F
    Transfus Apher Sci; 2013 Jun; 48(3):403-6. PubMed ID: 23664302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering.
    Webb IJ; Coral FS; Andersen JW; Elias AD; Finberg RW; Nadler LM; Ritz J; Anderson KC
    Transfusion; 1996 Sep; 36(9):782-8. PubMed ID: 8823450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous transplant: microbial contamination of hematopoietic stem cell products.
    Almeida ID; Schmalfuss T; Röhsig LM; Goldani LZ
    Braz J Infect Dis; 2012; 16(4):345-50. PubMed ID: 22846122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.
    Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G
    Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
    Sautois B; Fraipont V; Baudoux E; Fassotte MF; Hermanne JP; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus JM; Sondag D; Fillet G; Beguin Y
    Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation.
    Espinosa MT; Fox R; Creger RJ; Lazarus HM
    Transfusion; 1996 Sep; 36(9):789-93. PubMed ID: 8823451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.
    Jacobs MR; Good CE; Fox RM; Roman KP; Lazarus HM
    Transfusion; 2013 Nov; 53(11):2690-6. PubMed ID: 23461309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative immunomagnetic purging of peripheral blood stem cell harvests from breast carcinoma patients reduces tumor cell contamination while not affecting hematopoietic recovery.
    Pedrazzoli P; Lanza A; Battaglia M; Da Prada GA; Zambelli A; Perotti C; Ponchio L; Salvaneschi L; Robustelli della Cuna G
    Cancer; 2000 Jun; 88(12):2758-65. PubMed ID: 10870058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-thaw viability of cryopreserved hematopoietic progenitor cell grafts: does it matter?
    Vrhovac R; Perić Z; Jurenec S; Kardum-Skelin I; Jelić-Puskarić B; Jaksić B
    Coll Antropol; 2010 Mar; 34(1):163-9. PubMed ID: 20432746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time polymerase chain reaction in multiple myeloma: quantitative analysis of tumor contamination of stem cell harvests.
    Ladetto M; Omedè P; Sametti S; Donovan JW; Astolfi M; Drandi D; Volpato F; Giaccone L; Giaretta F; Palumbo A; Bruno B; Pileri A; Gribben JG; Boccadoro M
    Exp Hematol; 2002 Jun; 30(6):529-36. PubMed ID: 12063019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae.
    Klein MA; Kadidlo D; McCullough J; McKenna DH; Burns LJ
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1142-9. PubMed ID: 17085307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial contamination of harvested bone marrow and peripheral blood.
    Prince HM; Page SR; Keating A; Saragosa RF; Vukovic NM; Imrie KR; Crump M; Stewart AK
    Bone Marrow Transplant; 1995 Jan; 15(1):87-91. PubMed ID: 7742761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changing face of stem cell transplantation by the use of recombinant human granulocyte colony stimulating factor.
    Boogaerts MA; Demuynck H
    Eur J Cancer; 1994; 30A Suppl 3():S34-9. PubMed ID: 7535071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of pulsed-field gel electrophoresis to identify the source of bacterial contamination of peripheral blood progenitor cell products.
    Reich-Slotky R; Wu F; Della-Latta P; Savage DG; Schwartz J
    Transfusion; 2008 Nov; 48(11):2409-13. PubMed ID: 18657076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.